当前位置: X-MOL首页全球导师 国内导师 › 陈钧

个人简介

教育经历 1993.09 – 1997.06 上海医科大学药学院药学专业本科生,获理学学士学位 1999.09 – 2005.12 复旦大学药学院药剂学专业博士研究生,获理学博士学位 工作经历 1997.07 – 2001.12 复旦大学药学院药物分析教研室,助教 2002.01 – 2008.11 复旦大学药学院药剂学教研室,讲师 2008.12 – 2014.11 复旦大学药学院药剂学教研室,副教授,硕导 2014.12 – 至今 复旦大学药学院药剂学教研室,教授,博导 Awards & Honors The basic and clinical study of new targeting drugs and early diagnosis/intervention strategy for Alzheimer's disease. Shanghai Science and Technology Progress Award. (First prize, rank 8/15, 2017/11/16) Study on brain tumor targeting drug delivery system. Natural Science Award of Ministry of Education. (Second prize, rank 4/7, 2017/02/22) Study on brain tumor targeting drug delivery system. Shanghai Science and Technology Progress Award. (Second prize, rank 4/6, 2016/11/25) Mentor of Shanghai Graduate Outstanding Achievements (Thesis, Master graduate student: Hu Quanyin, 2016/06) Mentor of Shanghai Graduate Outstanding Achievements (Thesis, Master graduate student: Gu Guangzhi, 2015/05) Mentor of Shanghai Graduate Outstanding Achievements (Thesis, Master graduate student: Xia Huimin, 2014/04) Program for New Century Excellent Talents in University (2012/12/26) Chinese Pharmaceutical Association–Shijiazhuang Pharmaceutical Group Yong Pharmaceutics Scientist Awards (2012/12) Lectin-conjugated nanoparticles for drug delivery into brain following intranasal administration. Science and Technology Progress Award. (Second prize, rank 5/8, 2010/08/01)

研究领域

靶向递药系统 药物制剂体内药动学及成药性评价 药物新剂型与新制剂的研究开发

近期论文

查看导师新发文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Kang Ting, Huang Yukun, Zhu Qianqian, Cheng Hao, Pei Yuanyuan, Feng Jingxian, Xu Minjun, Jiang Gan, Song Qingxiang, Jiang Tianze, Chen Hongzhuan, Gao Xiaoling*, Chen Jun*,Necroptotic Cancer Cells-Mimicry Nanovaccine Boosts Anti-tumor Immunity with Tailored Immune-stimulatory Modality[J]. Biomaterials. DOI: 10.1016/j.biomaterials.2018.02.033 (IF:8.402) Kang Ting, Zhu Qianqian, Wei Dan, Feng Jingxian, Yao Jianhui, Jiang Tianze, Song Qingxiang, Wei Xunbin, Chen Hongzhuan, Gao Xiaoling *, Chen Jun *,Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis[J]. ACS Nano. 2017, 11, 1397-1411 (IF: 13.94) Yao Jianhui, Feng Jingxian, Gao Xiaoling, Wei Dan, Kang Ting, Zhu Qianqian, Jiang Tianze, Wei Xunbin, Chen Jun*,Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer[J]. Biomaterials. 2017, 113:1-17 (IF:8.402) Jiang Di , Gao Xiaoling, Kang Ting, Feng Xingye, YaoJianhui, Yang Mengshi, Jing Yixian, ZhuQianqian, Feng Jingxian, Chen Jun*, Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinatepoly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer[J]. Nanoscale. 2016, 8:3100-3118. (IF: 7.53) Feng Xingye, Yao Jianhui, Gao Xiaoling, Jing Yixian, Kang Ting, Jiang Di, Jiang Tianze, Feng Jingxian, Zhu Qianqian, Jiang Xinguo, Chen Jun *, Multitargeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy[J]. ACS Applied Materials & Interfaces. 2015, 7:27885-27899 (IF:7.145) Kang Ting, Zhu Qianqian, Jiang Di, Feng Xingye, Feng Jingxian, Jiang Tianze, Yao Jianhui, Jing Yixian, Song Qingxiang, Jiang Xinguo,Gao Xiaoling*, Chen Jun*,Synergistic targeting Tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment[J]. Biomaterials. 2016, 101:60-75 (IF:8.387) Feng Xingye, Jiang Di, Ting Kang, Yao Jianhui, Jing Yixian, Jiang Tianze, Feng Jingxian, Zhu Qianqian, Song Qingxiang, Dong Nan, Gao Xiaoling,* Chen Jun *,Tumor-Homing and Penetrating Peptide-Functionalized Photosensitizer-Conjugated PEG-PLA Nanoparticles for Chemo-Photodynamic Combination Therapy of Drug-Resistant Cancer. ACS Applied Materials & Interfaces. 2016, 8: 17817?17832 (IF:7.145) Hu Quanyin, Kang Ting, Feng Jingxian, Zhu Qianqian, Jiang Tianze, Yao Jianhui, Jiang Xinguo, Chen Jun*. Tumor Microenvironment and Angiogenic Blood Vessels Dual-Targeting for Enhanced Anti-Glioma Therapy. ACS Applied Materials & Interfaces. 2016, 8: 23568?23579 (IF:7.145) Feng Xingye, Gao Xiaoling, Kang Ting, Jiang Di, Yao Jianhui, Jing Yixian, Song Qingxiang, Jiang Xinguo, Liang Jianying*, Chen Jun*, Mammary-Derived Growth Inhibitor Targeting Peptide-Modified PEG-PLA Nanoparticles for Enhanced Targeted Glioblastoma Therapy[J]. Bioconjugate Chem. 2015, 26:1850-1861 (IF:4.513) Kang Ting, Jiang Mengyin, Jiang Di, Feng Xingye, Yao Jianhui, Song Qingxiang, Chen Hongzhuan, Gao Xiaoling*, Chen Jun*, Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex[J]. Molecular Pharmaceutics. 2015, 12:2947-2961 (IF:4.384) Kang Ting, Gao Xiaoling, Hu Quanyin, Jiang Di, Feng Xingye, Zhang Xue, Song Qingxiang, Yao Lei, Huang Meng, Jiang Xinguo, Pang Zhiqing, Chen Hongzhuan, Chen Jun*, iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas[J]. Biomaterials. 2014, 35:4319-4332 (IF:8.312) Miao Deyu, Jiang Mengyin, Liu Zhongyang, Gu Guangzhi, Hu Quanyin, Kang Ting, Song Qingxiang, Yao Lei, Li Wei, Gao Xiaoling,* Sun Mingjiang, Chen Jun *, Co-administration of Dual-Targeting Nanoparticles with Penetration Enhancement Peptide for Antiglioblastoma Therapy[J]. Mol. Pharmaceutics. 2014, 11:90?101. (IF: 4.787) Guangzhi Gu, Quanyin Hu, Xingye Feng, Xiaoling Gao, Jiang Menglin, Ting Kang , Di Jiang, Qingxiang Song, Hongzhuan Chen, Jun Chen *, PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy[J]. Biomaterials. 2014, 35:8215-8226. (IF:8.312) Gu Guangzhi, Gao Xiaoling, Hu Quanyin, Kang Ting, Liu Zhongyang, Jiang Mengyin, Miao Deyu, Song Qingxiang, Yao Lei, Tu Yifan, Pang Zhiqing, Chen Hongzhuan, Jiang Xinguo, Chen Jun *, The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells[J]. Biomaterials. 2013, 34:5138-5148 (IF:7.604) Hu Quanyin, Gao Xiaoling, Gu Guangzhi, Kang Ting, Tu Yifan, Liu Zhongyang, Song Qingxiang, Yao Lei, Pang Zhiqing, Jiang Xinguo, Chen Hongzhuan , Chen Jun*, Glioma therapy using tumor homing and penetrating peptide functionalized PEG-PLA nanoparticles loaded with paclitaxel[J]. Biomaterials. 2013, 34(22):5640-5650 (IF:7.604) Hu Quanyin, Gao Xiaoling, Kang Ting, Feng Xingye, Jiang Di, Tu Yifan, Song Qingxiang, Yao Lei, Jiang Xinguo, Chen Hongzhuan, Chen Jun*, CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels. Biomaterials, 2013, 34: 9496-9508 (IF:7.604) Gu Guangzhi, Xia Huimin, Hu Quanyin, Liu Zhongyang, Jiang Mengyin, Kang Ting, Miao Deyu, Tu Yifan, Pang Zhiqing, Song Qingxiang, Yao Lei, Chen Hongzhuan, Gao Xiaoling*, Chen Jun*, PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy[J]. Biomaterials. 2013,34(1): 196-208. (IF:7.604) Hu Quanyin, Gu Guangzhi, Liu Zhongyang, Jiang Mengyin, Kang Ting, Miao Deyu, Tu Yifan, Pang Zhiqing, Song Qingxiang, Yao Lei, Xia Huimin, Chen Hongzhuan, Jiang Xinguo, Gao Xiaoling*, Chen Jun*, F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery[J]. Biomaterials. 2013,34(4): 1135-1145. (IF:7.604) Liu Zhongyang, Jiang Mengyin, Kang Ting, Miao Deyu, Gu Guangzhi, Song Qingxiang, Yao Lei, Hu Quanyin, Tu Yifan, Pang Zhiqing, Chen Hongzhuan, Jiang Xinguo, Gao Xiaoling*, Chen Jun*, Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration[J]. Biomaterials. 2013,34(15): 3870-3881. (IF:7.604) Liu Zhongyang, Gao Xiaoling, Kang Ting, Jiang Mengyin, Miao Deyu, Gu Guangzhi, Hu Quanyin, Song Qingxiang, Yao Lei, Tu Yifan, Chen Hongzhuan, Jiang Xinguo, , Chen Jun*, B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide[J]. Bioconjug Chem, 2013;24(6):997-1007. (IF:4.58)

推荐链接
down
wechat
bug